key: cord-0965202-e3vap3x8
authors: da Silva Pedrosa, Marlus; Sipert, Carla Renata; Nogueira, Fernando Neves
title: Are the salivary glands the key players in spreading COVID‐19 asymptomatic infection in dental practice?
date: 2020-08-02
journal: J Med Virol
DOI: 10.1002/jmv.26316
sha: 4f9339aa3ae091fc798a771ed2e6fd46c109803f
doc_id: 965202
cord_uid: e3vap3x8

We read with great interest the article by Song et al.1 on the assessment of the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine proteases 2 (TMPRSS2) in salivary glands using publicly available databases. This article is protected by copyright. All rights reserved.

It has been widely reported that dental practice accounts for an increased risk of SARS-CoV-2 infection due to the close contact with the patient's airways and performance of aerosol-generating procedures. [10] [11] [12] Dental activities worldwide were profoundly affected by the COVID-19 pandemic. 13, 14 Several dental care facilities closed or limited appointments to urgent and emergency care. In addition, several recommendations were issued to provide dental care while mitigating the disease spread. [15] [16] [17] Mild, limited and asymptomatic infections, from individuals who never experience noticeable symptoms, have been widely reported for COVID-19. [18] [19] [20] However, even if asymptomatic infections are common, transmission from asymptomatic individuals was reported to be probably uncommon. 21 Overall, even though the current literature shows that salivary glands can be infected, we cannot affirm that they act as reservoirs for COVID-19 asymptomatic infections. Despite the indication of mouthwashes might cause confusion among the practitioners, along with other biosafety practices they would be able to decrease the risk of SARS-CoV-2 transmission by limiting viral load in saliva droplets and aerosols produced during dental procedures. 12, 22 The maintenance of oral healthcare is a serious problem that requires attention and appropriate measures. 23 The adoption of the preventive measures in dental setting to reduce viral load in mouth could be useful to provide elective care in asymptomatic patients in times of COVID-19. Studies are necessary to understand the real role of salivary glands in COVID-19 asymptomatic infections and transmission.

Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Salivary glands: potential reservoirs for COVID-19 asymptomatic infection

TMPRSS2 and ACE2 coexpression in SARS-CoV-2 salivary glands infection

Detection of 2019-nCoV in saliva and characterization of oral symptoms in COVID-19 patients

Regulation of enzyme activity

Gene regulatory networks

Inducible gene expression: diverse regulatory mechanisms

Transmission routes of 2019-nCoV and controls in dental practice

Overview of transnational recommendations for COVID-19 transmission control in dental care settings

SARS-CoV-2 and dentistry

Covid-19 diffusion and its impact on dental practice in distant countries with similar ethnic background

Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China

Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine

Changes of the patient management in dentistry during the pandemic caused by the SARS-coronavirus 2-initial perspectives of a clinic of operative dentistry in Europe

COVID-19 outbreak: succinct advice for dentists and oral healthcare professionals

Presumed asymptomatic carrier transmission of COVID-19

Potential presymptomatic transmission of SARS-CoV-2

Asymptomatic cases with SARS-CoV-2 infection

Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing

Is the oral cavity relevant in SARS-CoV-2 pandemic?

COVID-19: a novel coronavirus and a novel challenge for oral healthcare